Comparison · NCT05478174-sae
HSK3486 vs Propofol: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. HSK3486 vs Propofol: serious adverse events. Trial comparisons, record NCT05478174-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05478174-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0235 | 0.0108 | 0.0504 | wilson | |
| Risk in group 2 | 0.0155 | 0.00426 | 0.0548 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00803 | -0.0332 | 0.0371 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.52 | 0.311 | 7.41 | log | |
| Odds ratio, group 1 over group 2 | 1.53 | 0.304 | 7.69 | log | |
| Number needed to harm, for one more participant with a serious adverse event on HSK3486 than on Propofol | 125 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | HSK3486 | HSK3486 for general anesthesia induction~HSK3486: HSK3486 for induction of general anesthesia | 6 | 255 | EG000 |
| Group 2 | Propofol | Propofol for general anesthesia induction~Propofol: Propofol for induction of general anesthesia. | 2 | 129 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
Adverse Events (AEs) will be collected from the time of informed consent until the final study visit (Day 8). A treatment-emergent AE is defined as: an AE that occurs after the subject starts treatment with the IMP. If an Investigator becomes aware of a serious adverse event within 30 days after the last dose of study drug and it is considered by him/her to be caused by the study drug with a reasonable possibility, the event must be documented and reported.
Source ClinicalTrials.gov
Trial
- Title
- Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia
- NCT number
- NCT05478174
- Phases
- PHASE3
- Conditions
- General Anesthesia
- Interventions
- HSK3486, Propofol
- Lead sponsor
- Haisco-USA Pharmaceuticals, Inc.
- Results first posted
- 2024-10-29
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05478174?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05478174-sae